Ming Bu
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in ⓘ
- Toxicology 10
- Bioactive Compounds and Antitumor Agents 10
- Virology 8
- HIV Research and Treatment 8
- Co-authors
- Lisa M. Graham (6 shared papers)Burton B. Yang (5 shared papers)William G. Rice (5 shared papers)Catherine A. Schaeffer (5 shared papers)Mengmeng Zhang (1 shared paper)Qi‐Di Zhong (1 shared paper)Jim A. Turpin (4 shared papers)Robert W. Buckheit (4 shared papers)
- Journals
- Molecules (7 papers)Natural Product Communications (4 papers)Steroids (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Antiviral Research (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ming Bu
55 papers receiving 991 citations
Peers
Comparison fields: 5 of 93
- Virology 279
- Infectious Diseases 268
- Toxicology 44
- Renewable Energy, Sustainability and the Environment 144
- Pharmacology 113
Countries citing papers authored by Ming Bu
This map shows the geographic impact of Ming Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Bu more than expected).
Fields of papers citing papers by Ming Bu
This network shows the impact of papers produced by Ming Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Bu. The network helps show where Ming Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 195 | |
| 2 | 2020 | 150 | |
| 3 | 2016 | 70 | |
| 4 | 1997 | 67 | |
| 5 | 1993 | 64 | |
| 6 | 2016 | 56 | |
| 7 | 1998 | 44 | |
| 8 | 1996 | 32 | |
| 9 | 2017 | 30 | |
| 10 | 2017 | 24 | |
| 11 | 2019 | 24 | |
| 12 | 2001 | 19 | |
| 13 | 2022 | 18 | |
| 14 | 1997 | 18 | |
| 15 | 2017 | 17 | |
| 16 | 2019 | 16 | |
| 17 | 2014 | 13 | |
| 18 | 1987 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2014 | 12 |
About Ming Bu
Ming Bu is a scholar working on Toxicology, Virology, Pharmacology, Molecular Biology and Infectious Diseases, having authored 60 papers that have together received 1.0k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (11 papers), Bioactive Compounds and Antitumor Agents (10 papers), HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers), Synthesis and biological activity (7 papers), Genomics, phytochemicals, and oxidative stress (7 papers), Estrogen and related hormone effects (6 papers) and Phytochemical compounds biological activities (6 papers). The work is most often cited by research in Virology (279 citations), Infectious Diseases (268 citations), Toxicology (44 citations), Renewable Energy, Sustainability and the Environment (144 citations) and Pharmacology (113 citations). Ming Bu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lisa M. Graham, Burton B. Yang, William G. Rice, Catherine A. Schaeffer, Mengmeng Zhang, Qi‐Di Zhong, Jim A. Turpin, Robert W. Buckheit, David J. Clanton and John P. Bader. Their work appears in journals such as Molecules, Natural Product Communications, Steroids, Antimicrobial Agents and Chemotherapy and Antiviral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.